Isg15 controls p53 stability and functions

References

• Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O’Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429:86 - 92; http://dx.doi.org/10.1038/nature02514; PMID: 15103385
   PubMed Web of Science ®Google Scholar
• Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296 - 9; http://dx.doi.org/10.1038/387296a0; PMID: 9153395
   PubMed Web of Science ®Google Scholar
• Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299 - 303; http://dx.doi.org/10.1038/387299a0; PMID: 9153396
   PubMed Web of Science ®Google Scholar
• Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112:779 - 91; http://dx.doi.org/10.1016/S0092-8674(03)00193-4; PMID: 12654245
   PubMed Web of Science ®Google Scholar
• Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A 2002; 99:3099 - 104; http://dx.doi.org/10.1073/pnas.052706799; PMID: 11867746
   PubMed Web of Science ®Google Scholar
• Moscovitz O, Tsvetkov P, Hazan N, Michaelevski I, Keisar H, Ben-Nissan G, Shaul Y, Sharon M. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell 2012; 47:76 - 86; PMID: 22793692
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Reuven N, Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ 2010; 17:103 - 8; http://dx.doi.org/10.1038/cdd.2009.67; PMID: 19557012
   PubMed Web of Science ®Google Scholar
• An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392:405 - 8; http://dx.doi.org/10.1038/32925; PMID: 9537326
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 1995; 9:2143 - 56; http://dx.doi.org/10.1101/gad.9.17.2143; PMID: 7657166
   PubMed Web of Science ®Google Scholar
• Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001; 20:910 - 20; http://dx.doi.org/10.1038/sj.onc.1204171; PMID: 11314026
   PubMed Web of Science ®Google Scholar
• Durfee LA, Lyon N, Seo K, Huibregtse JM. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010; 38:722 - 32; http://dx.doi.org/10.1016/j.molcel.2010.05.002; PMID: 20542004
   PubMed Web of Science ®Google Scholar
• Korant BD, Blomstrom DC, Jonak GJ, Knight E Jr.. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem 1984; 259:14835 - 9; PMID: 6501319
   PubMed Web of Science ®Google Scholar
• Kim MJ, Latham AG, Krug RM. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 2002; 99:10096 - 101; http://dx.doi.org/10.1073/pnas.152327499; PMID: 12114540
   PubMed Web of Science ®Google Scholar
• Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 1992; 267:7806 - 13; PMID: 1373138
   PubMed Web of Science ®Google Scholar
• Malakhova O, Malakhov M, Hetherington C, Zhang DE. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 2002; 277:14703 - 11; http://dx.doi.org/10.1074/jbc.M111527200; PMID: 11854279
   PubMed Web of Science ®Google Scholar
• Yang P, Yu Z, Gandahi JA, Bian X, Wu L, Liu Y, Zhang L, Zhang Q, Chen Q. The identification of c-Kit-positive cells in the intestine of chicken. Poult Sci 2012; 91:2264 - 9; http://dx.doi.org/10.3382/ps.2011-02076; PMID: 22912461
   PubMed Web of Science ®Google Scholar
• Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389:300 - 5; http://dx.doi.org/10.1038/38525; PMID: 9305847
   PubMed Web of Science ®Google Scholar
• Liu M, Hummer BT, Li X, Hassel BA. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J Interferon Cytokine Res 2004; 24:647 - 54; http://dx.doi.org/10.1089/jir.2004.24.647; PMID: 15684817
   PubMed Web of Science ®Google Scholar
• Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 2004; 24:9592 - 600; http://dx.doi.org/10.1128/MCB.24.21.9592-9600.2004; PMID: 15485925
   PubMed Web of Science ®Google Scholar
• Wong JJ, Pung YF, Sze NS, Chin KC. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 2006; 103:10735 - 40; http://dx.doi.org/10.1073/pnas.0600397103; PMID: 16815975
   PubMed Web of Science ®Google Scholar
• Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 2004; 101:7578 - 82; http://dx.doi.org/10.1073/pnas.0402528101; PMID: 15131269
   PubMed Web of Science ®Google Scholar
• Zou W, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 2006; 281:3989 - 94; http://dx.doi.org/10.1074/jbc.M510787200; PMID: 16352599
   PubMed Web of Science ®Google Scholar
• Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005; 336:496 - 506; http://dx.doi.org/10.1016/j.bbrc.2005.08.132; PMID: 16139798
   PubMed Web of Science ®Google Scholar
• Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, Zhang DE. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 2003; 278:16608 - 13; http://dx.doi.org/10.1074/jbc.M208435200; PMID: 12582176
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Kobayashi T, Tamura S, Yokosawa H. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett 2006; 580:4521 - 6; http://dx.doi.org/10.1016/j.febslet.2006.07.032; PMID: 16872604
   PubMed Web of Science ®Google Scholar
• Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 2005; 102:10200 - 5; http://dx.doi.org/10.1073/pnas.0504754102; PMID: 16009940
   PubMed Web of Science ®Google Scholar
• Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur-E-Kamal A, Liu LF. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006; 66:921 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-1123; PMID: 16424026
   PubMed Web of Science ®Google Scholar
• Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006; 281:4334 - 8; http://dx.doi.org/10.1074/jbc.M512830200; PMID: 16407192
   PubMed Web of Science ®Google Scholar
• Okumura F, Zou W, Zhang DE. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 2007; 21:255 - 60; http://dx.doi.org/10.1101/gad.1521607; PMID: 17289916
   PubMed Web of Science ®Google Scholar
• Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 2002; 277:9976 - 81; http://dx.doi.org/10.1074/jbc.M109078200; PMID: 11788588
   PubMed Web of Science ®Google Scholar
• Bade VN, Nickels J, Keusekotten K, Praefcke GJ. Covalent protein modification with ISG15 via a conserved cysteine in the hinge region. PLoS One 2012; 7:e38294; http://dx.doi.org/10.1371/journal.pone.0038294; PMID: 22693631
   PubMedGoogle Scholar
• David Y, Ternette N, Edelmann MJ, Ziv T, Gayer B, Sertchook R, Dadon Y, Kessler BM, Navon A. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J Biol Chem 2011; 286:44104 - 15; http://dx.doi.org/10.1074/jbc.M111.234559; PMID: 21965653
   PubMed Web of Science ®Google Scholar
• Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 2010; 17:86 - 92; http://dx.doi.org/10.1038/cdd.2009.77; PMID: 19543236
   PubMed Web of Science ®Google Scholar
• Milner J, Cook A, Sheldon M. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40. Oncogene 1987; 1:453 - 5; PMID: 3330789
   PubMed Web of Science ®Google Scholar
• Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9:1595 - 602; PMID: 1691710
   PubMed Web of Science ®Google Scholar
• Meletis K, Wirta V, Hede SM, Nistér M, Lundeberg J, Frisén J. p53 suppresses the self-renewal of adult neural stem cells. Development 2006; 133:363 - 9; http://dx.doi.org/10.1242/dev.02208; PMID: 16368933
   PubMed Web of Science ®Google Scholar
• Zhu YH, Zhang CW, Lu L, Demidov ON, Sun L, Yang L, Bulavin DV, Xiao ZC. Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control. Stem Cells 2009; 27:1433 - 42; http://dx.doi.org/10.1002/stem.65; PMID: 19489034
   PubMed Web of Science ®Google Scholar
• Trinidad AG, Muller PA, Cuellar J, Klejnot M, Nobis M, Valpuesta JM, Vousden KH. Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity. Mol Cell 2013; 50:805 - 17; http://dx.doi.org/10.1016/j.molcel.2013.05.002; PMID: 23747015
   PubMed Web of Science ®Google Scholar
• Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849 - 52; http://dx.doi.org/10.1038/362849a0; PMID: 8479523
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425 - 79; http://dx.doi.org/10.1146/annurev.biochem.67.1.425; PMID: 9759494
   PubMed Web of Science ®Google Scholar
• Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82:373 - 428; PMID: 11917093
   PubMed Web of Science ®Google Scholar
• Baugh JM, Viktorova EG, Pilipenko EV. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol 2009; 386:814 - 27; http://dx.doi.org/10.1016/j.jmb.2008.12.081; PMID: 19162040
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, Ka SH, Oh KH, Kim KI, Zhang DE, Bang OS, et al. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 2009; 10:374 - 80; http://dx.doi.org/10.1038/embor.2009.23; PMID: 19270716
   PubMed Web of Science ®Google Scholar
• Pitha-Rowe I, Hassel BA, Dmitrovsky E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem 2004; 279:18178 - 87; http://dx.doi.org/10.1074/jbc.M309259200; PMID: 14976209
   PubMed Web of Science ®Google Scholar
• Guerra S, Cáceres A, Knobeloch KP, Horak I, Esteban M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 2008; 4:e1000096; http://dx.doi.org/10.1371/journal.ppat.1000096; PMID: 18604270
   PubMed Web of Science ®Google Scholar
• Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006; 103:6001 - 6; http://dx.doi.org/10.1073/pnas.0601523103; PMID: 16585524
   PubMed Web of Science ®Google Scholar
• Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000; 81:2215 - 8; PMID: 10950979
   PubMed Web of Science ®Google Scholar
• Osiak A, Utermöhlen O, Niendorf S, Horak I, Knobeloch KP. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005; 25:6338 - 45; http://dx.doi.org/10.1128/MCB.25.15.6338-6345.2005; PMID: 16024773
   PubMed Web of Science ®Google Scholar
• Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006; 443:214 - 7; http://dx.doi.org/10.1038/nature05077; PMID: 16957739
   PubMed Web of Science ®Google Scholar
• Jiang D, Brady CA, Johnson TM, Lee EY, Park EJ, Scott MP, Attardi LD. Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages. Proc Natl Acad Sci U S A 2011; 108:17123 - 8; http://dx.doi.org/10.1073/pnas.1111245108; PMID: 21969549
   PubMed Web of Science ®Google Scholar
• Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2007; 2:1896 - 906; http://dx.doi.org/10.1038/nprot.2007.261; PMID: 17703201
   PubMed Web of Science ®Google Scholar
• Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10:1794 - 805; http://dx.doi.org/10.1021/pr101065j; PMID: 21254760
   PubMed Web of Science ®Google Scholar